ACUITE BB+ | Downgraded | Issuer not co-operating*
-
RBI
Bank Loan Ratings
0.00
11.50
-
ACUITE A4+ | Downgraded | Issuer not co-operating*
RBI
Total Outstanding
0.00
65.94
-
-
-
Total Withdrawn
0.00
0.00
-
-
-
* The issuer did not co-operate; based on best available information.
Note:- For activities or ratings of instruments falling under the purview of Financial Sector Regulators other than SEBI, the grievance / dispute redressal mechanisms and investor protection mechanisms provided by SEBI shall not be available.
Rating Rationale
Acuite has downgraded the long-term rating to 'ACUITE BB+' (read as ACUITE Double B Plus) from 'ACUITE BBB-' (read as ACUITE Triple B Minus) and short-term rating to ‘ACUITE A4+’ (read as ACUITE A four plus) from ‘ACUITE A3’ (read as ACUITE A three) to the Rs. 65.94 crore bank facilities of Aarey Drugs and Pharmaceuticals Limited (ADPL).
The rating is now flagged as “Issuer Not-Cooperating” and is based on the best information available. The rating is downgraded on account of information risk.
About the Company
ADPL incorporated in 1990, is a Mumbai based company engaged in the business of manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates, specialty chemicals and offers a range of products for diverse industrial applications. The company caters to pharmaceuticals formulation manufacturers and pharmaceutical merchant exports. The company is also a supplier of industrial chemicals and solvents to different industries across the globe.
Unsupported Rating
Not Applicable
Non-cooperation by the issuer/borrower
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date. Acuité believes that information risk is a critical component in such ratings, and non-cooperation by the issuer along with unwillingness to provide information could be a sign of potential deterioration in its overall credit quality. This rating is therefore being flagged as “Issuer not cooperating”, in line with prevailing SEBI regulations and Acuité’s policies.
Limitation regarding information availability
Rating Sensitivities
Potential triggers (individual or collective) for an upward rating action:
No information provided by the issuer / available for Acuite to comment upon
Potential triggers (individual or collective) for a downward rating action:
No information provided by the issuer / available for Acuite to comment upon
Liquidity Position
No information provided by the issuer / available for Acuite to comment upon
ACUITE BBB- | Stable
(Downgraded from ACUITE BBB | Negative)
Cash Credit
Long Term
19.50
ACUITE BBB- | Stable
(Downgraded from ACUITE BBB | Negative)
Term Loan
Long Term
1.67
ACUITE BBB- | Stable
(Downgraded from ACUITE BBB | Negative)
Term Loan
Long Term
1.77
ACUITE BBB- | Stable
(Downgraded from ACUITE BBB | Negative)
Term Loan
Long Term
16.50
ACUITE BBB- | Stable
(Downgraded from ACUITE BBB | Negative)
Proposed Long Term Bank Facility
Long Term
5.06
ACUITE Not Applicable
(Withdrawn)
Proposed Short Term Bank Facility
Short Term
8.55
ACUITE Not Applicable
(Withdrawn)
23 Feb 2024
Proposed Short Term Bank Facility
Short Term
10.05
ACUITE A3+
(Reaffirmed)
Letter of Credit
Short Term
10.00
ACUITE A3+
(Reaffirmed)
Cash Credit
Long Term
19.50
ACUITE BBB | Negative
(Reaffirmed)
Proposed Long Term Bank Facility
Long Term
25.00
ACUITE BBB | Negative
(Reaffirmed)
Cash Credit
Long Term
15.00
ACUITE BBB | Negative
(Reaffirmed)
21 Nov 2023
Letter of Credit
Short Term
10.00
ACUITE A3+
(Reaffirmed)
Proposed Short Term Bank Facility
Short Term
10.05
ACUITE A3+
(Reaffirmed)
Cash Credit
Long Term
15.00
ACUITE BBB | Negative
(Reaffirmed)
Cash Credit
Long Term
19.50
ACUITE BBB | Negative
(Reaffirmed)
Proposed Long Term Bank Facility
Long Term
25.00
ACUITE BBB | Negative
(Reaffirmed)
07 Apr 2023
Letter of Credit
Short Term
10.00
ACUITE A3+
(Assigned)
Proposed Short Term Bank Facility
Short Term
10.05
ACUITE A3+
(Assigned)
Cash Credit
Long Term
19.50
ACUITE BBB | Stable
(Reaffirmed)
Cash Credit
Long Term
15.00
ACUITE BBB | Stable
(Assigned)
Proposed Long Term Bank Facility
Long Term
25.00
ACUITE BBB | Stable
(Assigned)
Lender’s Name
ISIN
Facilities
Listing Status
Regulated By
Date Of Issuance
Coupon Rate
Maturity Date
Quantum (Rs. Cr.)
Complexity Level
Rating
State Bank of India
Not avl. / Not appl.
Bank Guarantee (BLR)
Unlisted
RBI
Not avl. / Not appl.
Not avl. / Not appl.
Not avl. / Not appl.
0.50
Simple
ACUITE A4+ | Downgraded | Issuer not co-operating* ( from ACUITE A3 )
State Bank of India
Not avl. / Not appl.
Cash Credit
Unlisted
RBI
Not avl. / Not appl.
Not avl. / Not appl.
Not avl. / Not appl.
15.00
Simple
ACUITE BB+ | Downgraded | Issuer not co-operating* ( from ACUITE BBB- )
State Bank of India
Not avl. / Not appl.
Cash Credit
Unlisted
RBI
Not avl. / Not appl.
Not avl. / Not appl.
Not avl. / Not appl.
19.50
Simple
ACUITE BB+ | Downgraded | Issuer not co-operating* ( from ACUITE BBB- )
State Bank of India
Not avl. / Not appl.
Letter of Credit
Unlisted
RBI
Not avl. / Not appl.
Not avl. / Not appl.
Not avl. / Not appl.
10.00
Simple
ACUITE A4+ | Downgraded | Issuer not co-operating* ( from ACUITE A3 )
State Bank of India
Not avl. / Not appl.
PC/PCFC
Unlisted
RBI
Not avl. / Not appl.
Not avl. / Not appl.
Not avl. / Not appl.
1.00
Simple
ACUITE A4+ | Downgraded | Issuer not co-operating* ( from ACUITE A3 )
State Bank of India
Not avl. / Not appl.
Term Loan
Unlisted
RBI
Not avl. / Not appl.
Not avl. / Not appl.
30 Sep 2027
1.67
Simple
ACUITE BB+ | Downgraded | Issuer not co-operating* ( from ACUITE BBB- )
State Bank of India
Not avl. / Not appl.
Term Loan
Unlisted
RBI
Not avl. / Not appl.
Not avl. / Not appl.
31 Dec 2028
1.77
Simple
ACUITE BB+ | Downgraded | Issuer not co-operating* ( from ACUITE BBB- )
State Bank of India
Not avl. / Not appl.
Term Loan
Unlisted
RBI
Not avl. / Not appl.
Not avl. / Not appl.
30 Jun 2030
16.50
Simple
ACUITE BB+ | Downgraded | Issuer not co-operating* ( from ACUITE BBB- )
* The issuer did not co-operate; based on best available information.
Note:- For activities or ratings of instruments falling under the purview of Financial Sector Regulators other than SEBI, the grievance / dispute redressal mechanisms and investor protection mechanisms provided by SEBI shall not be available.